4//SEC Filing
Shabahang Shahrokh 4
Accession 0001213900-20-019990
CIK 0001726711other
Filed
Aug 2, 8:00 PM ET
Accepted
Aug 3, 8:27 PM ET
Size
7.2 KB
Accession
0001213900-20-019990
Insider Transaction Report
Form 4
Shabahang Shahrokh
DirectorCHIEF INNOVATION OFFICER
Transactions
- Exercise of In-Money
Common Stock
2020-07-24$11.25/sh+47,222$531,248→ 996,256 total - Exercise of In-Money
Series B Warrant
2020-07-24$11.25/sh−47,222$531,248→ 0 total(indirect: See Footnote)Exercise: $0.00From: 2020-07-02Exp: 2025-06-29→ Common Stock (47,222 underlying)
Footnotes (2)
- [F1]949,034 shares of common stock are owned beneficially by the Shabahang-Hatami Family Trust, Shahrokh Shabahang, Trustee.
- [F2]Held beneficially by the Shabahang-Hatami Family Trust, Shahrokh Shabahang, Trustee.
Documents
Issuer
ADiTx Therapeutics, Inc.
CIK 0001726711
Entity typeother
Related Parties
1- filerCIK 0001816754
Filing Metadata
- Form type
- 4
- Filed
- Aug 2, 8:00 PM ET
- Accepted
- Aug 3, 8:27 PM ET
- Size
- 7.2 KB